Affordable tirzepatide weight loss

Affordable Tirzepatide Weight Loss Mechanism of Action

Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. It works by:

Decreasing glucagon secretion

Reducing appetite and food intake

Slowing gastric emptying

Increasing insulin secretion

Affordable Tirzepatide Weight Loss Approved Uses

Tirzepatide is FDA-approved for:

• Treatment of type 2 diabetes in adults
• Chronic weight management in adults with obesity or overweight with at least one weight-related comorbidity

Efficacy

= For weight loss: In clinical trials, participants taking the highest dose (15 mg) lost an average of 20.9% of their body weight over 72 weeks
89.5% of participants maintained at least 80% of their weight loss when continuing tirzepatide treatment
For type 2 diabetes: Significantly improved blood glucose control compared to placebo

Administration

Given as a once-weekly subcutaneous injectionDosage is gradually increased over 4-20 weeks to reach target doses of 5 mg, 10 mg, or 15 mg weekly

Side Effects

The most common side effects are gastrointestinal, including:

Abdominal pain

Nausea

Diarrhea

Vomiting

Constipation

Precautions

Not recommended for patients with a personal/family history of medullary thyroid cancer or Multiple Endocrine Neoplasia syndrome type 2

Use caution in patients with a history of pancreatitis

Affordable tirzepatide weight loss Tirzepatide represents an important new treatment option for obesity and type 2 diabetes, offering significant weight loss and metabolic benefits when combined with lifestyle modifications. However, it requires careful patient selection and monitoring due to potential side effects and contraindications.